Shine On You Crazy ...
Health Care: Drugs
Biocryst Pharmaceuticals (BCRX: NASDAQ)
$1.71 0.00 | 0.00%
05/21/13 - 02:40 PM ET
589.21K / 1.46M
Vol / Avg. Vol:1.71 / 1.71
Open / Prev. Close:1.66 - 1.71
Today's Range:1.08 - 4.95
52 Wk Range:20.42%
Performance YTD:TheStreet Rating:
Portfolios with BCRX
- Portfolio NameUser Type
- ContributorStocks Under-$10 Setting Up...
- ContributorStocks Under-$10 Moving Hig...
- Usermo money
- ContributorBreakout Stocks Of The Week...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Moving Hig...
- ContributorBreakout Stocks Of The Week...
- ContributorHot Biotech Stocks Traded b...
- ContributorUnder-$10 Setting Up To Tra...
- Usertech
Latest BCRX Headlines from TheStreet
- July Options Now Available For BioCryst Pharmaceuticals (BCRX) 05.20.13 | 03:05 pm
- 5 Stocks Under $10 Set to Surge 05.02.13 | 02:05 pm
- 5 Health Care Stocks Under $10 to Watch 04.30.13 | 02:04 pm
- Stocks Gain as Alcoa Beats on Profit 04.08.13 | 04:04 pm
- BioCryst Won't Profit From Bird Flu Outbreak in China 04.08.13 | 03:04 pm
- Stock Futures Rise Ahead of Alcoa Earnings 04.08.13 | 07:04 am
- 3 Pharma Stocks Leaping on Unusual Volume 01.10.13 | 02:01 pm
- The Worst Biotech CEO of 2012 Is... 12.07.12 | 09:12 am
- Your Vote Counts: Who Is the Worst Biotech CEO of 2012? 12.04.12 | 08:12 am
- 5 Biotech Stocks Rising on Unusual Volume 11.20.12 | 02:11 pm
Press Releases for BCRX
- BioCryst Announces Initiation Of A Phase 1 Clinical Trial Of BCX4161 For The Treatment Of Hereditary Angioedema - Business Wire 03.25.13 | 06:03 am
- BioCryst Reports Fourth Quarter And Full Year 2012 Financial Results - Business Wire 02.19.13 | 06:02 am
- BioCryst To Announce Fourth Quarter & 2012 Financial Results On February 19, 2013 - Business Wire 02.05.13 | 01:02 pm
- BioCryst To Present At J.P. Morgan Healthcare Conference - Business Wire 01.02.13 | 01:01 pm
- BioCryst Pharmaceuticals Announces Focused Corporate Strategy And Restructuring - Business Wire 12.07.12 | 06:12 am
- BioCryst Pharmaceuticals And Presidio Pharmaceuticals Mutually Terminate Merger Transaction - Business Wire 11.30.12 | 06:11 am
- BioCryst Broad-Spectrum Antiviral BCX4430 Highly Effective Against Yellow Fever In A Preclinical Disease Model - Business Wire 11.12.12 | 06:11 am
- BioCryst Provides Corporate Update And Reports Third Quarter 2012 Financial Results - Business Wire 11.08.12 | 06:11 am
- BioCryst Announces Outcome From The Peramivir Phase 3 Interim Analysis - Business Wire 11.07.12 | 08:11 pm
- BioCryst To Report Third Quarter 2012 Financial Results On November 8, 2012 - Business Wire 11.01.12 | 02:11 pm
Partner Headlines for BCRX
- Pre-Market Most Active for Apr 15, 2013 : S, LIFE, CLWR, MTU, C, BAC, NOK, JCP, BBRY, BCRX, QQQ, FB - NASDAQ 04.15.13 | 12:04 pm
- Pre-Market Most Active for Apr 8, 2013 : BAC, BCRX, ARMH, QQQ, WFT, NXST, LUFK, ARCP, GM^B, MT, GNC, NOK - NASDAQ 04.08.13 | 12:04 pm
- Bird flu fears close China poultry markets - Financial Times 04.06.13 | 11:04 am
- Today's Market News To Trade On: 5 Stocks Moving On News - Seeking Alpha 11.09.12 | 09:11 am
- 2 Biotech Companies With Positive Results That May Be Headed In Opposite Directions - Seeking Alpha 11.08.12 | 09:11 am
- Zacks #1 Rank Additions for Monday - Tale of the Tape - Zacks 07.09.12 | 09:07 am
- Zacks #1 Rank Additions for Wednesday - Tale of the Tape - Zacks 06.27.12 | 09:06 am
- Today's Market News To Trade On: 5 Stocks Making News - Seeking Alpha 03.23.12 | 08:03 am
- UPDATE: Bird Flu Found in the Netherlands - Benzinga 03.19.12 | 01:03 pm
- Noteworthy Institutional 5% Ownership Filings Last Week - Seeking Alpha 03.19.12 | 09:03 am
